New University of Kentucky research shows that the immune system may target other remote areas of the brain to improve recovery after a stroke.
Read More

New technology developed at UCL is, for the first time, enabling cancer scientists to analyze the individual behavior of millions of different cells living inside lab-grown tumors – a breakthrough which could lead to new personalised cancer treatments.
Read More

Reducing animal product intake and following a primarily plant-based diet can decrease your risk of heart disease by minimizing the adverse effects of a gut-microbiome associated with increased risk of coronary heart disease, according to research published today in the Journal of the American College of Cardiology.
Read More

Chlorthalidone, the guideline-recommended diuretic for lowering blood pressure, causes more serious side effects than hydrochlorothiazide, a similarly effective diuretic, according to a new study led by researchers at Columbia University Irving Medical Center.
Read More

Over half of our genomes are made of repeating elements within DNA. In rare cases, these repeats can become unstable and grow in size. These repeat “expansions” cause neurodegenerative diseases such as ALS and dementia as well as learning disorders and autism in Fragile X syndrome.
Read More

The most recent guidelines for primary prevention recommend aspirin use for individuals ages 40 to 70 years who are at higher risk of a first cardiovascular event, but not for those over 70. Yet, people over 70 are at increasingly higher risks of cardiovascular events than those under 70.
Read More

An auditory illusion thought to synchronize brain waves and alter mood is no more effective than other sounds, according to research in adults recently published in eNeuro. The effect reported in other studies might be a placebo but could still have helpful effects for some people.
Read More

Scientists at the TSU Laboratory for Biophotonics, with specialists from the Tomsk Scientific Research Institute of Microsurgery, have developed a new tool for diagnosing lymphedema, a severe pathology that can develop after radical treatment of several oncological diseases.
Read More

In experiments with human cells and mice, researchers at the Johns Hopkins Kimmel Cancer Center report evidence that combining the experimental cancer medication TAK228 (also called sapanisertib) with an existing anti-cancer drug called trametinib may be more effective than either drug alone in decreasing the growth of pediatric low-grade gliomas.
Read More

The World Health Organization (WHO) on Monday warned against “blanket measures” over the novel coronavirus outbreak, pointing out the epidemic outside of China was only affecting a “tiny” proportion of the population.
Read More